Our Data
Welcome to TICKR-BIO, your premier destination for alternative data that empowers you to make informed investment decisions. Founded by OZMOSI, a leading healthcare data company, TICKR-BIO offers unparalleled data, insights, and tools for healthcare investment at every level. Our mission is clear: to equip investors with the knowledge and data they need to make smarter, more profitable choices.
How to Use TICKR-BIO
Investing in healthcare, particularly in biotech, requires a strategic approach due to the industry’s complexity and the high volatility associated with drug development. TickrBio.com offers a streamlined process to help investors make informed decisions by leveraging upcoming biotech events.
1. Review Upcoming Biotech Events
Start by exploring the list of upcoming biotech events on our website. This includes critical developments such as drug trials, FDA approvals, and more. By aligning these events with your investment strategy, considering factors like stock price, disease area, modality, and novel targets, you can narrow your focus to those that best match your objectives.
2. Understand Key Definitions
To effectively use the data, it’s essential to understand the terms and categories provided:
-
- Drug and Indication: Identify treatments or indications that interest you. Each drug is hyperlinked for detailed information.
- Phase: Learn about the current clinical phase of development, from preclinical research (P0) to post-approval events.
- Catalyst Date: The expected date for the event to occur, which is crucial for timing your investment.
- Catalyst Info: Detailed description of each event to aid in deeper research.
3. Make Informed Decisions
Once you’ve selected stocks of interest, TICKR-BIO’s advanced features, available in our Silver and Gold packages, can further refine your investment strategy:
-
- Volatility Potential: Predicts the likelihood of the event driving significant stock price movement, either positive or negative, along with a confidence interval.
- Portfolio Impact Index: Gauges the event’s potential impact on the company’s overall pipeline. A single event or announcement is more likely to influence the stock price for smaller companies with fewer products in development.
- Novel Target: Identifies whether the event involves a groundbreaking approach to disease treatment. Novel targets, while riskier, are more likely to drive substantial future returns for the developing company.
4. Strategize and Track Over Time
After identifying key events of interest, use the provided data to predict whether a stock will rise or fall around the catalyst date and invest accordingly. We recommend monitoring your investments over time, as patterns often emerge, such as stock price spikes just before an event. For those with a Gold subscription, the extended monitoring period offers a strategic advantage, allowing you to optimize your entry and exit points.
The Ultimate Tool for Informed Investment Decisions
Unmatched Expertise and Insight
OZMOSI brings a wealth of expertise in predictive analytics, risk assessments, and valuation models for the pharmaceutical industry. With over 20 years of experience in developing data-driven business and investment strategies, OZMOSI possesses a deep understanding of the marketplace and the critical data that drives it. This level of experience is crucial in today’s rapidly evolving healthcare landscape.
Navigating Complexity with Confidence
The emergence of new business models and the increasing complexity of drug development make predicting the impact of new products and deciding which ones to pursue more challenging than ever. At TICKR-BIO, we leverage our extensive experience and expertise to deliver unparalleled insights to our users. Our platform helps investors navigate market complexities, providing clarity by integrating data from multiple public sources into the most robust single source of BioPharm R&D data available.
The Power of Our Volatility Model
TICKR-BIO’s proprietary volatility model is second to none. Developed using over 20 years of point-in-time clinical trial data, our model is specifically designed to predict potential volatility for catalyst events, such as clinical trial outcomes. Our system continuously scans BioPharm news events, extracting upcoming announcements related to clinical outcomes. We then enhance this information with additional data about the product and catalyst events from other public sources, as well as our internal summaries of the clinical landscape.
Empowering Data-Driven Decisions
Whether you are monitoring critical dates for companies or analyzing market trends, TICKR-BIO equips you with the tools to make data-driven decisions and achieve higher returns. Our platform assembles critical information to provide clarity and confidence in your investment decisions, shaping the future of pharma and biopharma products.
Discover the TICKR-BIO Advantage
Join us at TICKR-BIO and discover the unparalleled advantage of informed investing. Our commitment to delivering the best data and insights ensures that you stay ahead of the curve in the ever-evolving healthcare market. Experience the difference with TICKR-BIO, where informed investment meets unrivaled expertise.